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A B S T R A C T
Background: The study aims were to estimate the incidence and risk factors for T2D in four
settings with different degree of urbanization and altitude in Peru.
Methods: Prospective cohort study conducted in urban, semi-urban, and rural areas in Peru.
An age- and sex-stratified random sample of participants was taken from themost updated
census. T2D was defined as fasting blood glucose P7.0 mmol/L or taking anti-diabetes
medication. Exposures were divided into two groups: geographical variables (urbanization
and altitude), and modifiable risk factors. Incidence, relative risks (RR), 95% confidence
intervals (95%CI), and population attributable fractions (PAF) were estimated.
Results: Data from 3135 participants, 48.8% males, mean age 55.6 years, was analyzed.
Overall baseline prevalence of T2D was 7.1% (95%CI 6.2–8.0%). At follow-up, including
6207 person-years of follow-up, a total of 121 new T2D cases were accrued, equating to
an incidence of 1.95 (95%CI 1.63–2.33) per 100 person-years. There was no urban to rural
gradient in the T2D incidence; however, compared to sea level sites, participants living in
high altitude had a higher incidence of diabetes (RR = 1.58; 95%CI 1.01–2.48). Obesity had
the highest attributable risk for developing T2D, although results varied by setting, ranging
from 14% to 80% depending on urbanization and altitude.
Conclusions: Our results suggest that the incidence of T2D was greater in high altitude sites.
New cases of diabetes were largely attributed to obesity, but with substantial variation in
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the contribution of obesity depending on the environment. These findings can inform
appropriate context-specific strategies to reduce the incidence of diabetes.
 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The burden of type 2 diabetes (T2D) is rising worldwide:
according to estimates from 2014, about 347 million people
are living with T2D [1]. Although T2D is preventable and con-
trollable through lifestyle modification, weight reduction, and
medication use [2], a recent systematic analysis reported an
increasing trend in the worldwide prevalence of T2D: from
8.3% among men and 7.5% among women in 1980, to 9.8%
and 9.2% in men and women in 2008 [3].
Information regarding the impact of risk factors on the
development of T2D in low- and middle-income countries
(LMIC) comes from cross-sectional reports instead of longitu-
dinal studies [4]. The heterogeneity of T2D and its depen-
dence on environmental factors support the need for
population-based, ethnically focused, and country-specific
studies of T2D incidence [5]. Given that much of the available
literature about the incidence of T2D arises from high-income
countries, no direct extrapolation can be made for ethnic
minorities and other populations living in and interacting
with different environments. These populations matter
because they may have lesser or poorer access to information
or healthcare services, including diagnosis and treatment.
Beyond the health sector, these populations present also dif-
ferent lifestyle traits that are largely driven by the environ-
ment they interact with, including a wide range of social
disparities across the lifespan. Taken together, these macro
forces place them at much higher risk of impaired T2D-
related health outcomes including micro-vascular or macro-
vascular complications and mortality. As economical but also
human resources are scarce in LMIC, such information would
provide a much needed strong platform to implement appro-
priate strategies to tackle the progression of T2D in LMIC con-
texts [6].
Peru is a middle-income country where noncommunica-
ble diseases are responsible for more than half of all causes
of deaths and 42% of total years of life lost [7]. Its diverse
geography—ranging from sea level to Andean mountains
to jungle rainforest areas—alongside unequal societal devel-
opment, and the rapid epidemiological and nutrition transi-
tion undergoing in the country [8], provides a unique
scenario where urban, semiurban, and rural settings coexist.
Many LMIC-based studies oriented to characterize the bur-
den of noncommunicable diseases have largely focused on
urban and rural differentials [9]. Given the complex
human-environment interactions, and considering the phys-
iological responses introduced, for example adapting to high
altitude areas [10], very little is known about the effect of
introducing combinations of rural and urban settings
together with lowland and high altitude environments on
shaping the burden of T2D. So far, available cross-sectional
reports signal towards a link between living at high altitude
and lower prevalence of T2D [11,12], but they cannot deter-
mine causality. Longitudinal studies looking at the geo-
graphical variation on the progression towards T2D by
altitude settings are scarce or even absent in LMIC. Given
the large population living at high altitude around the globe
[13], studying the incidence of T2D in high altitude settings
warrants attention.
Peru’s geographical predominance in the Andean region
makes it well positioned to adequately explore to what extent
altitudemay play a role in T2D heterogeneity in the velocity of
transitioning towardsmetabolic disorders, including diabetes.
As a result, there is an opportunity to better understand the
effects of rapid urbanization and geographical variation on
the progression of noncommunicable diseases, especially
focusing on T2D. Likewise, together with such geographical
diversity, there is a cultural and ethnical mixture that needs
to be considered, i.e. Quechua and Aymara populations are
among themost common ethnic groups living in high altitude
settings. Thus, it is hypothesized that well-known risk factors
will play a different role depending on the setting and envi-
ronmental factors surrounding individuals [14]. Therefore,
this study aimed to estimate the incidence of T2D in four set-
tings at different stages of urbanization and altitude in Peru.
In addition, modifiable lifestyle behaviors as well as anthro-
pometric markers were evaluated as potential risk factors,
and their respective population attributable fractions (PAF)
were estimated.
2. Methods
2.1. Study design and settings
The CRONICAS Cohort Study was conducted in four Peruvian
sites with varying degrees of altitude and urbanization (Fig. 1):
Pampas de San Juan de Miraflores, in Lima, Latin America’s
fourth largest city, a highly-urbanized area located at the
sea level; Puno, located at 3825 meters above sea level, con-
tributed one urban and one rural site; and Tumbes, a semiur-
ban setting in the coastal North of Peru, also at sea level [15].
Enrollment started in September 2010 and follow-up was con-
ducted, on average, 30 months after initial assessment. Rural
and urban sites were defined as per Peru’s National Institute
of Statistics and Informatics [16]: an urban area has P100
homes grouped together, whereas a rural area has <100
households grouped together or if there are P100 dispersed
households.
136 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 2 1 ( 2 0 1 6 ) 1 3 5 –1 4 5
2.2. Study population and sampling
Subjects were selected following a single-stage random sam-
pling procedure. Individuals aged P35 years who were per-
manent residents in the selected study sites were
potentially eligible. At each site, a sex and age (35–44, 45–54,
55–64, and 65+ years) stratified random sample of potential
participants was taken from the most updated census avail-
able. Only one subject per household was considered eligible
and invited to the study. Pregnant women, bedridden individ-
uals and those who were not able to provide consent were
excluded. The study sample is not nationally representative,
yet it is informative of the geographical diversity of study set-
tings and other Peruvian population that share similar socioe-
conomic and geographic characteristics. Further details about
the sampling procedures are described elsewhere [15].
At baseline, the cohort’s enrolment process was deemed
complete when at least 1000 subjects in Lima and Tumbes
sites were recruited together with 500 subjects from each of
Puno’s urban and rural areas. The criterion for completion
of recruitment was completion of questionnaires, blood labo-
ratory tests, and clinical measurements. At baseline, 11,554
subjects were randomly selected, 6872 contacted, and 4325
enrolled. Once the baseline assessment was due, there were
3601 subjects with complete questionnaires, of whom 3232
had complete clinical measurement, and 3135 with complete
blood samples (details in Fig. 2).
2.3. Definitions
The outcome of interest was T2D, defined as fasting blood
glucose P126 mg/dl (7.0 mmol/L) after a fasting period of
Fig. 1 – Map of Peru indicating the CRONICAS Cohort Study’s sites.
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8–12 h, or current T2D pharmacological treatment prescribed
by a physician [17]. In addition, for incidence calculations, a
new case was considered if participant reported having newly
started medication during follow-up and/or if blood glucose
criteria were met. Whole blood (13.5 ml) was withdrawn from
each participant, and fasting plasma glucose was measured
using an enzymatic colorimetric method (GOD-PAP; Modular
P-E/Roche-Cobas, Grenzach-Whylen, Germany).
Exposures of interest were divided in two groups:
geographical-related variables and modifiable risk factors.
Among the geographical variables, urbanization of the study
site (highly urbanized Lima, urban Puno, rural Puno, and
semi-urban Tumbes) and altitude (high altitude vs. sea level)
were considered. Modifiable risk factors evaluated at baseline
included: daily smoking of at least 1 cigarette per day, self-
reported; hazardous drinking, based on the Alcohol Use
Disorders Identification Test (P8 points in the score) [18];
number of hours of TV watching per day (<2, and P2 h per
day) [19]; transport-related physical inactivity, considering
only the transport-related physical activity domain of the
IPAQ and defined as not reporting walking or cycling trips in
the last 7 days (i.e. a single walk or cycle trip for 10 min or
more was considered to be classified as physical active)
[20]; and fruits and vegetables intake, categorized according
to the WHO recommendation (<5 and P5 portions per day)
[21].
Some anthropometric measurements mainly focused on
weight and adiposity together with some laboratory markers
were also assessed as potential risk factors: body mass index
(BMI, <25, 25–29.9, and P30 kg/m2); central obesity, based on
waist circumference and categorized according to cut-off
points for non-Caucasian population (<80 vs. P80 cm for
females, and <90 vs. P90 cm for males); and metabolic
syndrome [22]. In addition, hypertension, defined as systolic
blood pressure P140 mmHg or diastolic blood pressure
P90 mmHg or previous physician diagnosis and current
pharmacological treatment [23], was also evaluated.
Other variables assessed at baseline and considered in the
analysis were sex; age (35–44, 45–54, 55–64, and P65 years);
education (<7, 7–11, and P12 years); socioeconomic status
derived from assets possession and household facilities, and
split in tertiles (low, middle, and high); and first language
learnt at home (Spanish, Quechua or Aymara) as a proxy of
ethnicity.
2.4. Procedures
Fieldwork activities and procedures of the CRONICAS Cohort
Study have been described in detail elsewhere [15]. Briefly,
at baseline, fieldworkers visited households to contact poten-
tial participants and include them in the study. The follow-up
visit was conducted, on average, 30 months from baseline
assessment. In both evaluations, subjects responded to a
face-to-face questionnaire conducted by trained community
health workers using paper-based formats. After completing
the questionnaire, an appointment was made for a clinical
assessment in order to guarantee an adequate fasting period.
A total of 13.5 ml of blood was drawn at each clinical assess-
ment. Standing height and waist circumference, in triplicate,
was measured using standardized techniques. Weight was
assessed using the TBF-300A body composition analyzer
(TANITA Corporation, Tokyo, Japan). After a 5-min resting per-
iod, blood pressure was also measured in triplicate using an
automatic monitor OMRON HEM-780 validated for adult pop-
ulation, and the average of the last two measurements were
used in the analysis.
2.5. Biostatistical analysis
Analyses were conducted using STATA 13.0 (StataCorp, Col-
lege Station. TX, USA). Population characteristics were tabu-
lated according to the presence of T2D at baseline, and
comparisons were performed using Chi-squared test or Fisher
exact test accordingly. For longitudinal analyses, incidence
Fig. 2 – Baseline enrollment and follow-up of the CRONICAS Cohort Study.
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rates per 100 person-years of follow-up and 95% confidence
intervals (95%CI) were estimated excluding those who had
diabetes at baseline. Incidence estimates were obtained
according to predefined exposures of interest, i.e. geographi-
cal variables and modifiable risk factors.
Generalized linear models were used to determine the
strength of association between T2D and exposures of inter-
est, controlling for potential confounders. Overall and site-
specific crude and adjusted models were also generated to
determine relative risks (RR). Given the number of con-
founders and the potential correlation between them, the
variance inflation factor was used to determine collinearity
and exclude high correlated variables from the model if
needed. Finally, population attributable fractions (PAF) were
estimated by using the punaf command in STATA.
2.6. Ethics
Ethical approval was obtained from Institutional Review
Boards at Universidad Peruana Cayetano Heredia and Aso-
ciacio´n Bene´fica PRISMA, in Peru, and the Johns Hopkins
University, in the US. Participants provided verbal consent
due to major illiteracy rates, especially in rural areas.
3. Results
A total of 3135 subjects were included in the analysis, with a
mean age of 55.8 years (inter-quartile range: 45.3–65.0) and
48.5% were males. Characteristics of the study population
according to T2D diagnosis at baseline are detailed in Table 1.
3.1. Prevalence and incidence of diabetes
Overall prevalence of T2D at baseline was 7.1% (223/3140; 95%
CI 6.3–8.1%) and there was a clear difference between study
sites (p < 0.001). During the follow-up phase, 315 (10.0%) indi-
viduals were lost to follow-up, 187 (6.0%) did not provide a
blood sample, and 38 (1.2%) died. Of the 2,595 re-contacted,
223 (8.6%) were further excluded from incidence calculations
because of their diabetes status at baseline. Mean time of
follow-up was 2.4 (SD: 0.4) years, accruing a total of 6207
person-years of follow-up, and 121 new cases of T2D were
identified which translates into an overall incidence of 1.95
(95%CI 1.63–2.33) per 100 person-years. Further details of
T2D incidence, crude RR and 95%CI, organized by characteris-
tics of the study population are presented in Table 2.
3.2. Study site and modifiable factors as risk factors for
diabetes
A gradient towards higher incidence rate of T2D according to
urbanization was observable: there were 1.52 new T2D cases
per 100 person-years in rural Puno, while this estimate was
1.87, 1.96, and 2.50 for semi-urban Tumbes, Lima, and urban
Puno, respectively. However, after controlling for several con-
founders, there was no evidence of the impact of urbaniza-
tion on the incidence of T2D. Nonetheless, subjects living in
high altitude sites had a 58% higher risk of developing T2D
(RR = 1.58; 95%CI 1.01–2.48) when compared to those living
at sea level (Table 3).
None of themodifiable risk factors studiedwere associated
with an increased risk of T2D. However, variables related to
obesity, i.e. BMI, waist circumference, and metabolic syn-
drome, were associated with increased risk of developing
T2D. PAF of all obesity-related variables were over 20%
(Table 4). Site-specific analysis showed that transport-
related physical inactivity was the only factor that increased
T2D risk in the highly urbanized setting (RR = 2.96), whereas
TV watching for 2+ hours per day (RR = 1.56) and transport-
related physical inactivity (RR = 12.7) were associated with
greater risk of T2D in rural Puno (online supplement: E-
Table 1). Based on altitude, only transport-related physical
inactivity was associated with T2D (RR = 1.68) in sea level set-
tings (online supplement: E-Table 2).
Obesity at baseline had the highest attributable risk for the
developing T2D, although results varied markedly by setting:
PAF of obesity based on BMI was 59.2% in highly urbanized
Lima, 13.9% in urban Puno, 32.4% in rural Puno, and 79.8%,
in semi-urban Tumbes. Moreover, according to altitude, PAFs
of obesity was 69.8% in sea level areas, whereas it was
26.5% in high altitude settings.
4. Discussion
4.1. Main findings
Although there was no evidence of difference in the incidence
of T2D according to the degree of urbanization as depicted by
study sites; unadjusted results revealed an interesting
pattern: T2D incidence rate increased from rural Puno
throughout semi-urban Tumbes, Lima and urban Puno. On
the other hand, individuals from high altitude sites were
found to have a higher risk of developing T2D. Obesity, mea-
sured as BMI and waist circumference, was the factor with
higher attributable risk for T2D development, but PAF varied
substantially along with urbanization and altitude. The con-
tribution of the other modifiable risk factors in diabetes devel-
opment also differed by geographical characteristics of study
sites. This information affords understanding of diabetes-
related disease burden in LMIC by providing information,
derived from longitudinal studies, to identify T2D hotspots
for resource prioritization.
4.2. High altitude as a potential risk factor for diabetes
Similar to our baseline results, previous studies have reported
a lower prevalence of T2D in high altitude compared to sea
level settings [11,12]; however, longitudinal evidence of pro-
gression towards T2D in such settings is nearly absent. Our
study expands on such previous studies by demonstrating,
using a prospective design, that individuals living at high alti-
tude areas (3825 meters above sea level) are at greater risk of
incident diabetes after controlling for sociodemographic, life-
style behaviors, and anthropometric measurements.
Information regarding the impact of chronic exposure to
high altitude on developing diabetes, however, is limited.
The Atherosclerosis Risk in Communities (ARIC) cohort study
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reported that lower forced vital capacity (FVC) was an inde-
pendent predictor of incident type 2 diabetes [24]; however,
high altitude in our context has been associated with larger
lung capacity, but lower forced expiratory volume – forced
vital capacity (FEV/FVC) ratio [25]. A previous report from
our group, using a subsample of participants from Puno found
that, after controlling for several confounders, lower oxyhe-
moglobin saturation was associated with cardiometabolic
factors such as metabolic syndrome and higher waist circum-
ference [26]. There is some evidence that acute exposure to
high altitude settings, through hypoxia regulated pathways,
may increase insulin sensitivity [27]. However, other studies
in low-oxygen environments have found that, potentially
through systemic inflection [28] and sympathetic nervous
system activation [29], hypoxemia can disrupt glycemic
control.
Table 1 – Baseline population characteristics according to the presence of type 2 diabetes.
Without diabetes With diabetes p-value
Socio-demographics, n (%)
Sex n = 2902 n = 221 0.17
Male 1425 (49.1%) 98 (44.3%)
Age n = 2902 n = 222 <0.001
<45 years 743 (25.6%) 17 (7.7%)
45–54 years 743 (25.6%) 57 (25.7%)
55–64 years 720 (24.8%) 73 (32.9%)
65+ years 696 (24.0%) 75 (33.8%)
Education level n = 2902 n = 222 0.03
<7 years 1312 (45.2%) 120 (54.1%)
7–11 years 963 (33.2%) 67 (30.2%)
12+ years 627 (21.6%) 45 (15.8%)
Socioeconomic status n = 2904 n = 222 0.38
Lowest tertile 928 (32.0%) 61 (27.5%)
Middle tertile 981 (33.8%) 79 (35.6%)
Highest tertile 995 (34.3%) 82 (36.9%)
Study setting n = 2904 n = 222 <0.001
Lima 974 (33.5%) 59 (26.6%)
Urban Puno 481 (16.6%) 39 (17.6%)
Rural Puno 525 (18.1%) 17 (7.7%)
Tumbes 924 (31.8%) 107 (48.2%)
Setting altitude n = 2904 n = 222 0.004
High altitude 1006 (34.6%) 56 (25.2%)
First language learnt n = 2903 n = 222 0.004
Spanish 1825 (62.9%) 160 (72.1%)
Quechua 578 (19.9%) 42 (18.9%)
Aymara 500 (17.2%) 20 (9.0%)
Lifestyles behaviors, n (%) n = 2904 n = 222 <0.001
Family history of diabetes 345 (11.9%) 75 (33.8%)
n = 2904 n = 222 0.84
Daily smoking* 95 (3.3%) 6 (2.7%)
n = 2904 n = 222 0.01
Hazardous drinking 408 (14.1%) 18 (8.1%)
n = 2902 n = 222 0.007
TV watching for 2+ hours per day 1222 (42.1%) 114 (51.4%)
n = 2904 n = 222 <0.001
Transport-related physical inactivity 278 (9.6%) 41 (18.4%)
n = 2902 n = 222 <0.001
Fruits and vegetables (5+ portion/day) 111 (3.8%) 21 (9.5%)
Measurements, n (%)
Body mass index n = 2906 n = 222 <0.001
Normal (<25 kg/m2) 873 (30.0%) 42 (19.3%)
Overweight (P25 and <30 kg/m2) 1279 (44.0%) 89 (40.8%)
Obese (P30 kg/m2) 754 (26.0%) 87 (39.9%)
Waist circumference n = 2905 n = 218 <0.001
IDF central obesity 2077 (71.5%) 193 (88.5%)
Hypertension n = 2906 n = 218 <0.001
Measured or physician-diagnosed 693 (23.9%) 111 (50.9%)
Metabolic syndrome n = 2905 n = 217 <0.001
Yes 1273 (43.8%) 192 (88.5%)
Results may not add due to missing values.
* P-values were calculated using Fisher exact test instead of Chi-squared test.
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Alternatively, high altitude in our study may imply differ-
ences related to ethnicity given rural and urban Puno are pri-
marily Quechua and Aymara populations. As previous studies
have reported at least similar prevalence rates of diabetes in
high altitude aboriginal groups [30,31], and obesity markers
have lower population attributable fractions among individu-
als from high altitude settings, alternative explanations
might include changes in lifestyles, mainly characterized by
high consumption of saturated fat and refined sugars [32],
variables not available in our analysis. Genetic susceptibility
Table 2 – Incidence of type 2 diabetes according to population characteristics.
Incidence (95%CI) Bivariable model
per 100 person-years RR (95%CI)
Socio-demographics
Sex
Female 1.97 (1.54–2.52) 1 (reference)
Male 1.93 (1.49–2.50) 0.96 (0.68–1.36)
Age
35–44 years 1.24 (0.80–1.93) 1 (reference)
45–54 years 1.92 (1.35–2.73) 1.55 (0.89–2.68)
55–64 years 2.92 (2.18–3.89) 2.30 (1.37–3.84)
65+ years 1.71 (1.14–2.55) 1.45 (0.81–2.60)
Education level
<7 years 1.82 (1.38–2.41) 1 (reference)
7–11 years 1.64 (1.17–2.30) 0.83 (0.54–1.27)
12+ years 2.14 (1.49–3.08) 1.08 (0.69–1.69)
Socioeconomic status
Lowest tertile 1.66 (1.16–2.38) 1 (reference)
Middle tertile 1.72 (1.205–2.38) 0.96 (0.60–1.54)
Highest tertile 2.39 (1.83–3.12) 1.29 (0.84–2.00)
First language learnt
Spanish 2.00 (1.61–2.47) 1
Quechua 2.26 (1.55–3.29) 1.17 (0.77–1.78)
Aymara 1.25 (0.67–2.32) 0.78 (0.41–1.48)
Lifestyles behaviors
Family history of diabetes
No 1.81 (1.48–2.21) 1 (reference)
Yes 2.91 (1.93–4.38) 1.55 (1.01–2.41)
Daily smoking
No 1.92 (1.60–2.31) 1 (reference)
Yes 2.70 (1.21–6.01) 1.34 (0.61–2.94)
Hazardous drinking
No 1.91 (1.58–2.32) 1 (reference)
Yes 2.18 (1.38–3.47) 1.13 (0.70–1.84)
TV watching
<2 h per day 1.85 (1.45–2.36) 1 (reference)
2+ hours per day 2.08 (1.60–2.70) 1.08 (0.76–1.53)
Transport-related physical inactivity
No 1.83 (1.51–2.23) 1 (reference)
Yes 2.76 (1.72–4.45) 1.51 (0.92–2.48)
Fruits and vegetables consumption
<5 portions per day 1.93 (1.60–2.31) 1 (reference)
5+ portions per day 2.57 (1.15–5.71) 1.28 (0.58–2.84)
Measurements
Body mass index
Normal (<25 kg/m2) 0.87 (0.53–1.45) 1 (reference)
Overweight (P25 and <30 kg/m2) 1.68 (1.26–2.24) 1.81 (1.02–3.21)
Obese (P30 kg/m2) 3.48 (2.70–4.49) 3.72 (2.13–6.50)
Waist circumference (IDF)
No central obesity 0.80 (0.47–1.39) 1 (reference)
Central obesity 2.35 (1.95–2.84) 2.79 (1.58–4.92)
Hypertension
No 1.76 (1.42–2.19) 1 (reference)
Yes 2.54 (1.85–3.49) 1.43 (0.98–2.07)
Metabolic syndrome
No 0.89 (0.62–1.28) 1 (reference)
Yes 3.16 (2.57–3.90) 3.42 (2.28–5.13)
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 2 1 ( 2 0 1 6 ) 1 3 5 –1 4 5 141
should also be considered; however, the genetic admixture in
Peruvians is very high [33], with many groups sharing com-
mon Native American ancestry and thus requiring a deeper
study to understand its contribution to the observed differ-
ences in the incidence of diabetes.
Future studies are needed to understand the pathophysio-
logical mechanisms of T2D progression in high altitude.
Among the alternative explanations, we ought to consider
the role of fetal programming, low birth weight, neonatal
determinants, and childhood chronic undernutrition on the
adult onset of diabetes and other metabolic traits. In addition,
growth variability in early life may play a contributing role.
Some studies have reported an association between low birth
weight, or low weight at one year, with the risk of diabetes in
adult life [34]. Other studies have linked shorter adult stature
[35], or shorter relative leg length [36], with adult diabetes
risk. Relative leg length is not correlated with birth weight,
and acts as a marker of the quality of post-natal growth
[37]. The mechanism underlying these associations has been
identified as nutritional impairment of pancreatic beta cells
during early development [38]. Of particular relevance here,
we have previously shown that children born at high altitude
in Peru have relatively shorter legs compared to those born at
low altitude [39]. If, as in other studies, these contrasting
growth patterns mark variability in pancreatic beta cell devel-
opment, then the poorer growth of high-altitude children
would be predicted to increase their diabetes risk for any
given level of obesity.
4.3. Obesity and other risk factors for incident diabetes
Obesity, assessed as BMI, waist circumference, and partially
by metabolic syndrome, was the risk factor with the highest
attributable risks for incident T2D across sites in our study.
Both being overweight and obese have been associated with
increased risk of diabetes, cancer, cardiovascular diseases,
among other comorbidities [40]. Based on the PAF, central
obesity was the most important risk factor explaining the
burden of diabetes in our population. Central obesity shows
PAF values ranging from 26% in urban Puno to 86% in semiur-
ban Tumbes, almost similar to the variation of BMI. A previ-
ous meta-analysis concluded that waist circumference was
Table 3 – Association between study site characteristics and the risk of diabetes: crude and adjusted models.
Incidence (95%CI) Crude model Adjusted modela Adjusted modelb
per 100 person-years RR (95%CI) RR (95%CI) RR (95%CI)
Study setting
Lima 1.96 (1.46–2.62) 1 (reference) 1 (reference) 1 (reference)
Urban Puno 2.50 (1.66–3.76) 1.19 (0.73–1.93) 1.32 (0.75–2.30) 1.45 (0.84–2.48)
Rural Puno 1.52 (0.86–2.68) 0.71 (0.38–1.33) 1.13 (0.56–2.29) 1.52 (0.73–3.18)
Tumbes 1.87 (1.37–2.53) 0.96 (0.64–1.45) 1.02 (0.66–1.58) 0.86 (0.54–1.36)
Setting altitude
Low 1.91 (1.55–2.36) 1 (reference) 1 (reference) 1 (reference)
High 2.05 (1.47–2.85) 1.20 (0.82–1.75) 1.23 (0.79–1.91) 1.58 (1.01–2.48)
a The model was adjusted by sex, age, education level, and socioeconomic status.
b Model adjusted for sex, age, education level, socioeconomic status, family history of diabetes, daily smoking, hazardous drinking, TV
watching for 2+ hours per day, transport-related physical inactivity, fruits and vegetables consumption, body mass index, and metabolic
syndrome.
Table 4 – Modifiable factors and the risk of type 2 diabetes: adjusted models and population attributable fractions (PAF).
Adjusted modela Population attributable fraction
RR (95%CI)
Lifestyles behaviors
Daily smoking 1.35 (0.61–3.01) 1.3%
Hazardous drinking 1.24 (0.74–2.09) 2.9%
TV watching for 2+ hours per day 1.12 (0.78–1.61) 5.0%
Transport-related physical inactivity 1.67 (0.98–2.84) 5.7%
Fruits and vegetables: 5+ portions/day 1.24 (0.56–2.74) 1.0%
Measurements
Body mass index (vs. normal)
Overweight (P25 and <30 kg/m2) 1.89 (1.04–3.43) 36.5%
Obese (P30 kg/m2) 3.99 (2.23–7.14) 54.9%
Central obesity (IDF) 2.88 (1.63–5.09) 58.3%
Hypertension 1.35 (0.91–2.01) 8.2%
Metabolic syndrome 3.34 (2.23–5.02) 52.4%
Population attributable fractions were calculated using the punaf command in STATA.
a The model was adjusted by sex, age, education level, socioeconomic status, and study setting.
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a modestly stronger predictor of diabetes than body mass
index, although this difference was not significant [41]. Thus,
as in other countries, the pandemic of obesity, and hence car-
diovascular disease and T2D, is reaching even themost poorer
and remote areas of LMIC. For example, TV watching and
transport-related physical inactivity, indicators of seden-
tarism, and related to obesity, were strongly associated with
incident diabetes in rural Puno, pointing out that even rural
areas are currently being affected by unhealthy lifestyle
behaviors.
4.4. Public health implications
Over the course of 2.5 years, we found a major difference in
expected patterns of incidence of T2D by study site, a pattern
that would have gone unnoticed if we were to rely solely on
prevalence or disease burden type of investigations. As about
140 million people worldwide live at high altitudes, i.e.
>2500 meters above sea level [13], our findings suggest a sig-
nal towards a prioritization of high altitude areas in diabetes
prevention efforts to avoid the permanent installation of T2D
and metabolic damage in low-prevalence settings.
Our results also suggest that effective strategies are
needed to reduce the burden of diabetes in our populations.
Obesity should be the center of these interventions, which
would decrease dramatically the emergence of new cases of
diabetes. These interventions should be cognizant of the dif-
ferent magnitude of effect of obesity on diabetes incidence by
geographical settings [4], which could introduce pragmatic
elements to design adequate interventions with sufficient
intensity. Our results regarding population attributable frac-
tions are reassuring: if obesity, a modifiable risk factor, were
not to be present, the proportion of diabetes that could be
reduced would be at least half of cases of diabetes, and such
impact could be higher depending on the characteristics of
the study site. Yet, despite the availability of evidence of
effective interventions that reduce the risk of developing dia-
betes involving healthier diets and exercise, as well as phar-
macological treatment [2], the obesity pandemic has
dramatically accelerated in the last decades. Much of the
information regarding the rise of obesity, especially in LMIC,
is derived from estimates aggregated at the national level,
yet our findings call for close monitoring of obesity trends
within country and beyond country-level aggregates, espe-
cially for rural populations as well as those living at high alti-
tude settings.
4.5. Strengths and limitations
To our knowledge, this is the first longitudinal study assessing
the progression of diabetes according to geographical varia-
tion and altitude. Our estimates were calculated using a
population-based study in settings with different geographi-
cal characteristics. However, some limitations must be noted.
First, T2D was defined using fasting blood glucose and current
newly started treatment instead of the gold standard, i.e. oral
glucose tolerance test; as a result, some cases of diabetes may
have been missed. Nevertheless, our definitions and results
are similar to those used in existing reports. Second, some
selection bias might affect our results. Despite the random
selection of participants at baseline, we selected specific
study sites which might not be representative of all Peruvian
settings. Moreover, the rejection rate at baseline was not triv-
ial (see details in Fig. 2). In addition, as other longitudinal
studies, rejection to participate during follow-up may have
biased our estimates. Third, results could also reflect the
effect of unmeasured confounders such as diet patterns. We
included fruits and vegetables intake but we did not assess
fat intake, refined-sugar consumption, among other dietary
products. At some extent, this limitation might have been
overcome by including sex and socioeconomic status in the
regression model. A study in Mexico reported different levels
of fat, saturated fat, and cholesterol between men and
women and among low, middle and high socioeconomic level
[42]. Third, power might be an issue, mainly due to short term
follow-up, i.e. 30 months on average, as many recognized risk
factors for diabetes were not significant in our results. How-
ever, as PAFs assess the contribution of a risk factor to a dis-
ease, they can provide a better understanding of the role of
these factors in the involved populations. Fourth, over-
adjustment could be an issue as our models included several
variables implicit with urbanization, i.e. education, socioeco-
nomic status, TV watching, physical inactivity, etc. However,
our models involved variables that are part of the usual
assessment of traditional risk factors. In addition, two differ-
ent models, partially and full adjusted, have been provided to
explore the possibility of over-adjustment.
5. Conclusions
Geographical variation, mainly high altitude, may play a role
in the risk of developing T2D and the pathophysiology leading
to this relationship needs to be further investigated and
understood. Moreover, impact of risk factors on incident dia-
betes cases varied substantially according to geographical
characteristics, and new cases of diabetes can be largely attri-
butable to obesity. These findings can well support the design
of appropriate context-specific disease intervention strategies
aimed to reduce the rising burden of diabetes.
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